Exploring how in-silico methods are accelerating antileishmanial drug discovery through computational biology and AI.
Groundbreaking research reveals how Th17 and Treg cells orchestrate the immune response in chronic cutaneous leishmaniasis caused by Leishmania tropica.
Breakthrough fluorescent antibody technique transforms diagnosis of cutaneous leishmaniasis in Tunisia, offering hope against this disfiguring parasitic disease.
Discover how PCR technology is revolutionizing the diagnosis of leishmaniasis, a parasitic disease affecting millions worldwide.
Discover how researchers identified the Lmj_04_BRCT domain as a novel therapeutic target for leishmaniasis, a devastating neglected tropical disease affecting millions worldwide.